Propyphenazone: Pyrazolone analgesic in combination preparations for headaches

Propyphenazone is a non-opioid analgesic from the pyrazolone class of active substances, similar to metamizole and phenazone. It has analgesic and antipyretic effects, but without significant anti-inflammatory action. In Germany, propyphenazone is mainly available in combination preparations together with paracetamol and caffeine (for example Saridon with paracetamol and caffeine, indicated for migraine treatment).

Propyphenazone was introduced in the 1950s as a safer alternative to aminophenazone, which was withdrawn from the market due to carcinogenic properties. Today propyphenazone plays a rather subordinate role, as paracetamol and NSAIDs such as ibuprofen cover most indications better or at least equally well. In certain fixed combinations, it continues to be used as an over-the-counter pain reliever.

Mechanism of action

The exact mechanism of action of propyphenazone is not fully understood. It presumably inhibits cyclooxygenase 1 and 2 both peripherally and centrally, similar to other pyrazolones. The analgesic effect is predominantly central, with activation of descending inhibitory pathways and modulation of nociceptive processing in the central nervous system.

The antipyretic effect is based on inhibition of prostaglandin synthesis in the hypothalamus, which resets the setpoint in fever. Unlike classic NSAIDs, propyphenazone has only weak anti-inflammatory action and irritates the gastric mucosa less.

Pharmacokinetically, propyphenazone is rapidly absorbed after oral administration (bioavailability approximately 90 percent), half-life approximately 2 to 3 hours, which is why frequent daily doses are necessary. Elimination is renal after conjugation in the liver. In combination preparations, caffeine enhances the analgesic effect by approximately 40 percent (Sergeant study and subsequent studies).

Areas of application

• Mild to moderate headaches: tension headache, occasional migraine
• Toothache: short-term relief
• Menstrual pain (dysmenorrhea): as an alternative to NSAIDs
• Muscle and joint pain: short-term symptomatic therapy
• Fever: antipyretic indication

Propyphenazone is not suitable for the treatment of chronic pain, but serves for occasional, acute use.

Dosage and administration

Adults: 250 to 500 mg propyphenazone individually or in combination preparations every 4 to 6 hours as needed, maximum daily dose 1,500 mg. For combination preparations: dosage according to package insert, usually one to two tablets every 4 to 6 hours.

Duration of use: without medical consultation not longer than 3 days in a row or more than 10 days per month, to avoid medication-induced headache and renal effects.

In children: in Germany not recommended for use in children under 14 years of age due to insufficient safety data and alternative options such as paracetamol or ibuprofen.

Side effects

Common: usually well tolerated. Nausea, stomach complaints, allergic skin reactions.

Occasional: dizziness, fatigue, sleep disturbances (especially with combination preparations containing caffeine).

Rare, but important: pyrazolones can in rare cases cause severe blood count changes such as agranulocytosis, thrombocytopenia and aplastic anemia, similar to metamizole. The risk with propyphenazone is significantly lower than with metamizole or the historical aminophenazone, but not zero. Severe skin reactions such as Stevens Johnson syndrome, anaphylactic reactions are also possible.

Important: propyphenazone is contraindicated in patients with known pyrazolone allergy or severe reaction in their history. If unexpected rash, fever or signs of blood count changes occur, seek medical evaluation.

Drug interactions

• Other NSAIDs or analgesics: additive risks, preferably do not combine without indication
• Anticoagulants (warfarin, NOACs): possible INR increase with prolonged use
• Methotrexate: pyrazolones can increase MTX levels, especially with high-dose MTX
• Other myelotoxic agents: additive risk of bone marrow suppression
• Caffeine in combination preparations: can cause sleep disturbances, tachycardia and restlessness, especially in sensitive individuals

Special information

Pregnancy and breastfeeding: propyphenazone is avoided in pregnancy, especially in the third trimester. Use is not recommended during breastfeeding, paracetamol is the safest alternative.

Medication-induced headache: with frequent use for more than 10 days per month, there is a risk that the pain relievers themselves induce headaches. Strict limitation of use is important.

Diagnosis of pain: chronic headaches, migraine and other pain syndromes require medical diagnosis. Exclusively symptomatic self-medication can obscure serious conditions.

Renal insufficiency: caution in renal insufficiency, as pyrazolones and in combination paracetamol or caffeine can impair renal function (analgesic nephropathy with long-term abuse).

You might also be interested in

• Paracetamol, standard therapy for mild pain
• Ibuprofen, NSAID for pain with inflammation
• Metamizole, another pyrazolone with higher efficacy profile
• Caffeine, effect enhancer in pain reliever combinations
• Sumatriptan, specific migraine therapy

Frequently asked questions

Sources

• Gelbe Liste, Propyphenazone active ingredient profile
• DGN guideline therapy of migraine attack and tension headache
• BfArM, Federal Institute for Drugs and Medical Devices
• EMA Product information propyphenazone preparations